Budamate 400 Transhaler

(0 customer reviews)
Price range: $33.49 through $91.00

In Stock

Budamate 400 Transhaler

Price range: $33.49 through $91.00
In Stock
Secure
Checkout
Free
Shipping
30-Day
Returns
Quality
Guaranteed
Quantity
Safe Payment

All major cards & wallets accepted

Premium Quality

Tested to highest standards

24/7 Support

We're here whenever you need us

Money-Back Guarantee

30-day no questions asked

What Is Budamate 400 Transhaler?

Budamate 400 Transhaler is a fixed-dose combination inhaled corticosteroid + long-acting beta-2 agonist (ICS + LABA) pMDI. The "Transhaler" is Lupin's proprietary pressurised metered dose inhaler device — featuring a built-in dose counter that displays the number of remaining actuations, helping patients track usage and plan refills before running out. The 400 designation refers to the high-dose 400 mcg Budesonide per actuation — appropriate for patients requiring Step 3–4 asthma therapy or those with frequent COPD exacerbations where standard-strength ICS + LABA combinations have proven insufficient. Budamate 400 Transhaler is not a rescue inhaler. It will not relieve an acute asthma attack that has already started. Patients must always keep a separate short-acting bronchodilator on hand for emergency use. This inhaler's role is exclusively preventive and maintenance-based — working over days and weeks to reduce the underlying inflammation and airway constriction that drives chronic respiratory disease. Patients who need a complete overview of combination inhaler options can browse the full asthma and COPD inhaler range at Ed Care Store, including lower-strength ICS + LABA alternatives.

What Is Budamate 400 Transhaler Used For?

Moderate-to-Severe Asthma Maintenance

Budamate 400 Transhaler is indicated for regular maintenance therapy of persistent asthma in adults and children over 6 years where treatment with a combination inhaled corticosteroid and long-acting bronchodilator is appropriate — specifically at the higher Budesonide dose of 400 mcg for patients not adequately controlled on lower-strength combinations (100–200 mcg Budesonide equivalents). Asthma at this level of severity is characterised by daily symptoms, frequent nocturnal awakenings due to wheeze or breathlessness, significant limitation of activity, and FEV1 below 60–80% of predicted normal on spirometry. Regular twice-daily use of Budamate 400 reduces airway inflammation, prevents bronchospasm, improves peak flow, decreases the frequency of exacerbations requiring oral steroid rescue, and reduces the need for daily reliever inhaler use.

COPD with Frequent Exacerbations

Budamate 400 Transhaler is also prescribed for symptomatic maintenance treatment of COPD in adults — particularly those with a documented history of repeated exacerbations (two or more per year) who remain poorly controlled on bronchodilator monotherapy. At the 400 mcg Budesonide dose, the inhaler provides stronger anti-inflammatory airway protection, reducing exacerbation frequency, decreasing hospitalisation risk, and improving day-to-day breathing capacity and exercise tolerance. Patients experiencing acute COPD or asthma exacerbations requiring short-term systemic corticosteroid therapy should discuss Omnacortil 40 Mg Tablet (Prednisolone) with their physician — available on the same platform for oral steroid burst courses alongside ongoing inhaler maintenance.

How Does Budamate 400 Transhaler Work?

Budesonide 400 Mcg – High-Dose Inhaled Corticosteroid

Budesonide is a second-generation glucocorticoid corticosteroid with high topical pulmonary anti-inflammatory potency and relatively low systemic bioavailability. Once inhaled, it deposits directly on bronchial airway mucosa and binds to intracellular glucocorticoid receptors. The activated receptor-steroid complex enters the cell nucleus, where it:
  • Upregulates anti-inflammatory proteins: Stimulates production of lipocortin-1 (annexin-1), which inhibits phospholipase A2 — the enzyme initiating the arachidonic acid cascade — blocking synthesis of pro-inflammatory prostaglandins and leukotrienes.
  • Suppresses cytokine transcription: Inhibits production of IL-4, IL-5, IL-13, and TNF-α — the key cytokines responsible for eosinophilic and mast cell-driven airway inflammation in asthma, and neutrophilic inflammation in COPD.
  • Reduces airway oedema: Decreases vascular permeability and plasma exudation into airway mucosa — reducing mucosal thickening and airway lumen narrowing.
  • Suppresses mucus hypersecretion: Inhibits goblet cell overactivity and the excessive, viscous mucus production that further obstructs airflow in both asthma and COPD.
  • Maintains beta-2 receptor density: Prevents downregulation of bronchial beta-2 adrenoreceptors that can occur with prolonged LABA use — preserving the bronchodilatory effectiveness of Formoterol over time.
  At the 400 mcg dose, Budesonide provides significantly more robust anti-inflammatory coverage compared to 100–200 mcg formulations — directly addressing the greater degree of airway inflammation present in moderate-to-severe disease.

Formoterol Fumarate 6 Mcg – Long-Acting Bronchodilator (LABA)

Formoterol is a selective long-acting beta-2 adrenergic agonist (LABA) with a uniquely advantageous pharmacological profile among LABAs. Unlike Salmeterol — which takes 10–20 minutes to reach bronchodilatory effect — Formoterol begins relaxing airway smooth muscle within 1 to 3 minutes of inhalation while maintaining its duration of action for up to 12 hours. This combination of rapid onset and extended duration makes Formoterol the preferred LABA component for combination maintenance inhalers. Formoterol stimulates beta-2 receptors on bronchial smooth muscle, activating adenylate cyclase and elevating intracellular cAMP. This triggers smooth muscle relaxation, causing bronchodilation — reducing airway resistance and restoring airflow within minutes of use. The combined pharmacological action of Budesonide's anti-inflammatory coverage and Formoterol's rapid and sustained bronchodilation makes Budamate 400 Transhaler clinically superior to either ingredient used alone at equivalent doses — the pharmacological synergy between ICS and LABA is well-established in international respiratory guidelines. Patients considering an alternative Budesonide + Formoterol combination at a lower Budesonide strength may also explore Foracort 200 Inhaler (Budesonide 200 mcg + Formoterol, by Cipla) — available on the same platform as a step-down option.

How to Use Budamate 400 Transhaler Correctly

Correct MDI inhaler technique is critical to ensure the medication reaches the lower airways and delivers its full clinical benefit. Follow these steps precisely:
  • Check the dose counter: Before use, confirm the number of remaining doses on the counter window. If it reads zero, the inhaler needs replacing even if it still feels weighted.
  • Remove the mouthpiece cap: Pull the cap downward and check that the mouthpiece is clear of dust, fluff, or debris.
  • Prime if new or unused for 7+ days: Release 2 test sprays into the air (away from the face) before first use or after any period of non-use exceeding one week.
  • Shake vigorously: Hold the inhaler upright and shake firmly for 5 seconds to ensure uniform drug suspension before each actuation.
  • Breathe out fully: Exhale completely and slowly away from the inhaler to empty your lungs.
  • Seal and position: Place the mouthpiece firmly between your teeth and form a complete seal with your lips around it.
  • Inhale and actuate simultaneously: Begin breathing in slowly and deeply through the mouth and at the same moment press the canister firmly downward to release one puff. Continue inhaling until your lungs are completely full.
  • Hold breath for 10 seconds: Remove the inhaler from your mouth and hold your breath for a full 10 seconds — or as long as comfortably possible — before exhaling slowly.
  • Second dose: If a second puff is prescribed, wait 60 seconds, reshake the inhaler, and repeat steps 5 through 8.
  • Rinse mouth immediately: After every use, rinse your mouth thoroughly with water and spit it out. Do not swallow the rinse. This is essential to prevent oral thrush and reduce hoarseness from residual Budesonide.
  • Use a spacer device: A spacer (valved holding chamber) is strongly recommended — it eliminates coordination difficulty between actuation and inhalation, reduces oropharyngeal drug deposition, and significantly improves pulmonary drug delivery, especially for children and elderly patients.

Budamate 400 Transhaler Dosage Guidelines

Dosing is always determined by your prescribing physician based on disease severity, previous ICS therapy, age, and clinical response. General guidance:
Patient Group Dose Per Actuation Standard Regimen Max Daily Dose
Adults ≥18 yrs – Moderate Asthma 400 mcg Bud + 6 mcg Form 1 puff twice daily (morning & evening) 2 puffs/day (800 mcg Bud / 12 mcg Form)
Adults ≥18 yrs – Severe Asthma / COPD 400 mcg Bud + 6 mcg Form 1–2 puffs twice daily as prescribed 4 puffs/day — only under physician direction
Adolescents 12–17 yrs – Moderate Asthma 400 mcg Bud + 6 mcg Form 1 puff twice daily 2 puffs/day
Children 6–11 yrs Lower-dose formulation preferred As directed by paediatric physician Consult paediatric specialist
Elderly patients (≥65 yrs) 400 mcg Bud + 6 mcg Form 1 puff twice daily As tolerated; monitor for side effects
Important: Doses should always be taken 12 hours apart (e.g. 8 AM and 8 PM) for consistent 24-hour airway coverage. Do not skip doses because symptoms appear controlled — this indicates the medication is working. Abrupt discontinuation can trigger rapid rebound of symptoms and potentially severe exacerbations. Never double-dose if a dose is missed. For patients who require a fast-acting rescue bronchodilator alongside their Budamate 400 maintenance regimen, Asthalin Inhaler (Salbutamol) provides immediate short-acting airway relief and should always be carried as emergency backup.

Key Benefits of Budamate 400 Transhaler

  • High-Dose ICS for Advanced Disease Control: The 400 mcg Budesonide dose addresses the more significant airway inflammation present in moderate-to-severe asthma and frequent-exacerbation COPD — delivering the anti-inflammatory potency that lower-strength combinations cannot achieve.
  • Rapid Bronchodilator Onset within 1–3 Minutes: Formoterol's uniquely fast onset among LABAs means patients feel airway opening quickly after each dose — unlike Salmeterol-containing inhalers where bronchodilation can take 10–20 minutes.
  • Sustained 12-Hour Coverage: Twice-daily dosing provides continuous, round-the-clock airway protection — eliminating symptomatic gaps between doses that can occur with shorter-acting medications.
  • Dose Counter Built-In: Lupin's Transhaler device incorporates a clearly visible dose counter — an important safety and adherence feature that prevents patients from using an empty canister without knowing it.
  • Proven Exacerbation Reduction: Clinical evidence for the Budesonide + Formoterol combination consistently demonstrates significant reduction in both the frequency and severity of asthma attacks and COPD exacerbations, reducing emergency department visits and hospitalisation rates.
  • Improves Spirometry Markers: Regular use leads to measurable, sustained improvements in FEV1, FVC, and peak expiratory flow rate — objective markers of reduced airway obstruction.
  • HFA-Propelled CFC-Free Formulation: The HFA (hydrofluoroalkane) propellant produces a softer, warmer aerosol plume compared to CFC inhalers — reducing "cold freon" effect and improving patient acceptance and adherence, particularly in paediatric and elderly patients.
  • Affordable Lupin Generic: Budamate 400 Transhaler provides Symbicort-equivalent Budesonide + Formoterol therapy at a significantly lower generic price point — making step-up treatment financially sustainable for long-term use.
  For patients being stepped down from high-dose to standard-dose ICS + LABA therapy after achieving good control, Digihaler FB 200 Inhaler (Budesonide 200 mcg + Formoterol) — a Glenmark-manufactured combination — is available as a lower-strength option on the same platform.

Common Side Effects of Budamate 400 Transhaler

Side effects with Budamate 400 Transhaler are generally mild to moderate and largely preventable with correct inhaler technique and mouth rinsing:

Common Side Effects

  • Oral thrush (oropharyngeal candidiasis): White patches in the mouth or throat from residual Budesonide deposition. Completely preventable by rinsing and spitting after every use. A spacer device further reduces this risk.
  • Hoarseness of voice (dysphonia): Steroid residue on vocal cords causes temporary voice changes. Rinsing the mouth and using a spacer significantly reduce incidence.
  • Sore throat or throat irritation
  • Headache
  • Cough — mild, usually transient after inhalation
  • Upper respiratory tract infections — slightly increased susceptibility due to local immunosuppression
  • Palpitations and increased heart rate: Related to Formoterol's beta-2 agonist activity — usually mild and transient, particularly at initiation
  • Mild tremor: Fine tremor, predominantly in the hands, is a recognised beta-2 agonist class effect — usually reduces with continued use
  • Nausea and stomach discomfort
  • Muscle pain (myalgia) and back pain
  • Sleep disturbances — more commonly reported with the 400 mcg Budesonide dose compared to lower strengths
 

Rare – With High-Dose or Long-Term Use

  • Adrenal suppression: Significant systemic Budesonide absorption at high doses may partially suppress HPA axis activity — most clinically relevant in children and patients on multiple steroid therapies simultaneously
  • Reduced bone mineral density: Long-term high-dose ICS use — calcium and Vitamin D supplementation is advisable for patients on extended therapy
  • Hypokalaemia (low blood potassium): Formoterol can lower serum potassium — more pronounced at high doses or when combined with diuretics. Potassium monitoring advised in susceptible patients
  • Hyperglycaemia: Inhaled corticosteroids can affect blood glucose — diabetic patients require closer monitoring during therapy
 

Who Should Not Use Budamate 400 Transhaler?

Budamate 400 Transhaler is contraindicated or requires special caution in:
  • Known hypersensitivity to Budesonide, Formoterol Fumarate, milk proteins (the HFA formulation contains lactose), or any other excipient
  • Acute asthma attacks or status asthmaticus: This maintenance inhaler is not effective for emergency relief — use a fast-acting bronchodilator for acute episodes
  • Children under 6 years of age: Safety and efficacy not established below this age threshold
  • Active pulmonary tuberculosis (TB): Inhaled corticosteroids may promote TB progression without adequate antitubercular cover
  • Serious active respiratory infections: Bacterial, viral, or fungal pulmonary infections may be worsened by corticosteroid-mediated immunosuppression
  Use with caution in: patients with thyrotoxicosis, phaeochromocytoma, cardiovascular disease (arrhythmias, hypertrophic obstructive cardiomyopathy, hypertension, heart failure), diabetes mellitus, hypokalaemia, osteoporosis, glaucoma, and epilepsy. Pregnancy and breastfeeding: use only when clearly indicated and the benefit outweighs risk — consult your obstetrician or respiratory physician before continuing or initiating therapy.

Key Drug Interactions

Interacting Drug / Class Risk of Interaction Clinical Recommendation
Strong CYP3A4 Inhibitors (ketoconazole, ritonavir, cobicistat, itraconazole) Significantly increased systemic Budesonide levels; adrenal suppression risk Avoid concurrent use; if unavoidable, use lowest effective ICS dose and monitor closely
Other LABA-Containing Inhalers (salmeterol, indacaterol) Additive cardiovascular effects; risk of beta-2 overdose symptoms Do not use with other LABA medicines — Budamate 400 already contains Formoterol
Non-Selective Beta-Blockers (propranolol, carvedilol) Antagonise Formoterol's bronchodilatory effect; risk of severe bronchospasm Contraindicated in asthma; use cardioselective beta-blockers only with caution
Loop & Thiazide Diuretics (furosemide, hydrochlorothiazide) Additive hypokalaemia — particularly dangerous with high Formoterol doses Monitor serum potassium; supplement if needed
MAO Inhibitors & Tricyclic Antidepressants Potentiate Formoterol's cardiovascular effects Use only under close medical supervision; at least 14 days apart from MAOIs
Systemic Corticosteroids (concurrent use) Additive adrenal suppression, Cushing's syndrome risk Minimise concurrent systemic steroid exposure; taper carefully when transitioning
Xanthine derivatives (theophylline, aminophylline) Additive hypokalaemia and cardiac arrhythmia risk Monitor potassium and ECG; dose adjustment may be required
Mifepristone May reduce Budesonide efficacy Avoid concurrent use
 

Budamate 400 vs Comparable High-Dose ICS + LABA Inhalers

Understanding how Budamate 400 Transhaler compares with other combination inhalers helps patients and prescribers select the most appropriate therapy:
Feature Budamate 400 Transhaler Symbicort 400/12 Turbuhaler Foracort 400 (Cipla) Digihaler SF 250 (Glenmark)
ICS Component Budesonide 400 mcg Budesonide 400 mcg Budesonide 400 mcg Fluticasone 250 mcg
LABA Component Formoterol 6 mcg Formoterol 12 mcg Formoterol 6 mcg Salmeterol 25 mcg
Device Type HFA pMDI (Transhaler) Dry Powder (DPI) HFA pMDI HFA pMDI
Dose Counter ✓ Built-in ✓ Built-in Varies Varies
LABA Onset 1–3 minutes (Formoterol) 1–3 minutes (Formoterol) 1–3 minutes (Formoterol) 10–20 minutes (Salmeterol)
Duration 12 hours 12 hours 12 hours 12 hours
Manufacturer Lupin Ltd. AstraZeneca Cipla Ltd. Glenmark
Price Point ✓ Affordable Generic Premium Brand ✓ Affordable Generic ✓ Affordable Generic
  Patients who are stepping up from a Fluticasone + Salmeterol combination and transitioning to a Budesonide + Formoterol regimen should also note that Digihaler SF 250 Inhaler (Fluticasone + Salmeterol) remains an effective choice for those who respond better to Fluticasone's different corticosteroid profile, and is available on the same platform.

Practical Tips for Maximum Benefit from Budamate 400 Transhaler

  • Never use Budamate 400 as an emergency rescue inhaler: Always carry a separate short-acting reliever. If you need your rescue inhaler more than twice a week, contact your doctor — your maintenance therapy may need review.
  • Rinse your mouth without exception: Even once-missed mouth rinse can allow oral thrush to establish. Make it an automatic post-inhalation habit every single time.
  • Use a spacer device wherever possible: A valved holding chamber dramatically improves pulmonary deposition, reduces local side effects, and makes the inhaler more accessible for patients with limited hand-breath coordination.
  • Monitor your peak flow regularly: A peak flow diary helps identify deteriorating control before symptoms escalate to crisis level — allowing timely medical intervention.
  • Do not adjust your dose without consultation: Increasing or decreasing the dose independently can destabilise respiratory control. Always work with your prescriber to adjust therapy.
  • Attend regular spirometry and review appointments: Lung function should be assessed every 6–12 months to guide therapy step-up or step-down decisions as your condition evolves.
  Patients also managing corticosteroid-induced or general skin-related inflammatory conditions alongside respiratory disease may find that the Beclate Inhaler 200 Mcg (Beclomethasone) — a different ICS — offers an alternative inhaled corticosteroid profile available on the same platform.

Storage Instructions for Budamate 400 Transhaler

  • Store below 30°C in a cool, dry location — keep away from heat sources, radiators, and direct sunlight
  • Do not refrigerate or freeze — cold temperatures can reduce HFA aerosol performance and clog the valve mechanism
  • Store the inhaler with the mouthpiece cap on to prevent contamination
  • Keep canister at room temperature — cold canisters produce less effective aerosol; warm the canister in your hand for 30 seconds if stored in a cool environment
  • Do not pierce, puncture, or incinerate the pressurised canister even when empty
  • Keep out of reach of children and pets at all times
  • Check the dose counter before and after each use — replace the inhaler when the counter approaches zero
  • Do not use past the printed expiry date
 

Why Order Budamate 400 Transhaler from Ed Care Store?

Ed Care Store (edcarestore.com) is a dedicated online healthcare pharmacy making quality-assured respiratory and general health medicines accessible to patients who need them. When you order Budamate 400 Transhaler through Ed Care Store, here is what you can rely on:
  • Authentic Lupin Pharmaceuticals Products: All Budamate 400 Transhalers are sourced directly from verified supply channels — Lupin-manufactured, GMP-certified, and fully genuine.
  • Discreet, Tamper-Evident Delivery: Respiratory medications are dispatched in secure, plain packaging — your health privacy is protected at every step.
  • Competitive Generic Pricing: Access to Budesonide 400 mcg + Formoterol maintenance therapy at affordable generic prices — significantly more accessible than branded Symbicort equivalents.
  • Full Respiratory Range Available: Browse the complete respiratory medicines collection — including ICS-only, LABA-only, LAMA, rescue inhalers, oral steroids, and other combination options — all in one trusted platform.
  • Broader Healthcare Coverage: Men managing concurrent health needs alongside respiratory care can also access Kamagra Gold 100 Mg and other men's health products on the same platform.
  • Health Information Resources: Visit the Ed Care Store health blog for informational content on respiratory health management, treatment comparisons, and lifestyle strategies for better breathing.
  Advanced asthma and frequent COPD exacerbations require an equally advanced maintenance response. Budamate 400 Transhaler's high-dose Budesonide and rapid-onset Formoterol combination provides the dual-action control that moderate-to-severe respiratory disease demands — and with Ed Care Store, accessing your supply is straightforward, affordable, and fully discreet. Disclaimer: The content on this page is for informational purposes only and does not substitute professional medical advice, diagnosis, or treatment. Budamate 400 Transhaler is a prescription-only medicine. Always consult a qualified respiratory specialist or healthcare provider before starting, adjusting, or stopping any inhaler therapy. Ed Care Store stocks products exclusively from verified, licensed pharmaceutical manufacturers.

Specifications

Budamate 400 Transhaler 3 Inhaler, 6 Inhaler, 9 Inhaler

Frequently Asked Questions

We offer free standard shipping on all orders. Orders are processed within 1-2 business days and typically arrive within 5-7 business days.

We accept returns within 30 days of purchase. Items must be in original condition with tags attached.

Yes! All our products come with a comprehensive warranty against defects in materials or workmanship.
Budamate 400 Transhaler
$33.49 – $91.00Price range: $33.49 through $91.00
Budamate 400 Transhaler – enlarged view
EdCareStore Footer Image

Address
5954 Old Cove Heath Rd Eupora, Mississippi(MS), 39744

US Call/Text
+1 (914) 999-2631

Email
support@edcarestore.com

Trending Products

Vardenafil

Blue Pill

Tadalafil

Oral ED Jelly

Bimatoprost

Shop by category

Shop All

Men’s Health

Women’s Health

Eye Care

Asthma

Diabetes

Company

About Us

Reviews

Medicine Policy

Shipping Policy

Communication Policy

Disclaimer Policy

User guide

Indian Pharmacies

Protect Yourself

Regulated Medicine

Returns & Exchanges

Safe and Secure Shopping

FAQs

Copyright © 2026 Edcarestore | All Rights Reserved

Request Your Free Sample

Fill out the form below and our pharmacist will get in touch!

Please select an option
Full name is required
Valid phone number is required
Valid email address is required
Please describe the sample you're looking for

Thank You!

Your free sample request has been received.

Due to high demand, our pharmacist will reach out to you within the next 3-4 business days.